China
· Delayed Price · Currency is CNY Betta Pharmaceuticals Statistics
Total Valuation
SHE:300558 has a market cap or net worth of CNY 23.73 billion. The enterprise value is 25.61 billion.
| Market Cap | 23.73B |
| Enterprise Value | 25.61B |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Jun 17, 2025 |
Share Statistics
SHE:300558 has 420.73 million shares outstanding. The number of shares has decreased by -0.47% in one year.
| Current Share Class | 420.73M |
| Shares Outstanding | 420.73M |
| Shares Change (YoY) | -0.47% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 3.76% |
| Owned by Institutions (%) | 12.69% |
| Float | 231.81M |
Valuation Ratios
The trailing PE ratio is 58.13 and the forward PE ratio is 31.06.
| PE Ratio | 58.13 |
| Forward PE | 31.06 |
| PS Ratio | 7.72 |
| PB Ratio | 4.21 |
| P/TBV Ratio | 9.71 |
| P/FCF Ratio | 93.13 |
| P/OCF Ratio | 24.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.88, with an EV/FCF ratio of 100.50.
| EV / Earnings | 63.30 |
| EV / Sales | 8.33 |
| EV / EBITDA | 26.88 |
| EV / EBIT | 45.45 |
| EV / FCF | 100.50 |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.42.
| Current Ratio | 0.62 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 2.50 |
| Debt / FCF | 9.37 |
| Interest Coverage | 10.05 |
Financial Efficiency
Return on equity (ROE) is 6.91% and return on invested capital (ROIC) is 4.38%.
| Return on Equity (ROE) | 6.91% |
| Return on Assets (ROA) | 3.82% |
| Return on Invested Capital (ROIC) | 4.38% |
| Return on Capital Employed (ROCE) | 8.02% |
| Revenue Per Employee | 1.57M |
| Profits Per Employee | 206,281 |
| Employee Count | 1,961 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.82 |
Taxes
In the past 12 months, SHE:300558 has paid 21.43 million in taxes.
| Income Tax | 21.43M |
| Effective Tax Rate | 5.23% |
Stock Price Statistics
The stock price has increased by +68.04% in the last 52 weeks. The beta is 0.54, so SHE:300558's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +68.04% |
| 50-Day Moving Average | 54.40 |
| 200-Day Moving Average | 50.73 |
| Relative Strength Index (RSI) | 52.19 |
| Average Volume (20 Days) | 14,231,057 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300558 had revenue of CNY 3.07 billion and earned 404.52 million in profits. Earnings per share was 0.97.
| Revenue | 3.07B |
| Gross Profit | 2.49B |
| Operating Income | 564.38M |
| Pretax Income | 410.08M |
| Net Income | 404.52M |
| EBITDA | 949.99M |
| EBIT | 564.38M |
| Earnings Per Share (EPS) | 0.97 |
Balance Sheet
The company has 597.77 million in cash and 2.39 billion in debt, giving a net cash position of -1.79 billion or -4.25 per share.
| Cash & Cash Equivalents | 597.77M |
| Total Debt | 2.39B |
| Net Cash | -1.79B |
| Net Cash Per Share | -4.25 |
| Equity (Book Value) | 5.63B |
| Book Value Per Share | 13.25 |
| Working Capital | -790.69M |
Cash Flow
In the last 12 months, operating cash flow was 961.47 million and capital expenditures -706.68 million, giving a free cash flow of 254.79 million.
| Operating Cash Flow | 961.47M |
| Capital Expenditures | -706.68M |
| Free Cash Flow | 254.79M |
| FCF Per Share | 0.61 |
Margins
Gross margin is 81.07%, with operating and profit margins of 18.36% and 13.16%.
| Gross Margin | 81.07% |
| Operating Margin | 18.36% |
| Pretax Margin | 13.34% |
| Profit Margin | 13.16% |
| EBITDA Margin | 30.91% |
| EBIT Margin | 18.36% |
| FCF Margin | 8.29% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.34%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.34% |
| Dividend Growth (YoY) | 17.02% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 39.35% |
| Buyback Yield | 0.47% |
| Shareholder Yield | 0.83% |
| Earnings Yield | 1.70% |
| FCF Yield | 1.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHE:300558 has an Altman Z-Score of 4.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 6 |